Novo Nordisk A/S ADR (NYSE:NVO) - Share price - Overview


Stock Report

Novo Nordisk A/S NVO

Last Price
$52.17

Day Change
-0.46|-0.87%

As of 21/03/2019
16:56:55 EDT | USD
Minimum 15 Minutes Delay.

Last Close52.63
Day Range52.15 - 52.53
Mkt Cap126.00Bil
52-Wk Range41.23 - 52.83
Yield %2.43
ISINUS6701002056
Volume1,260,138
P/E-
P/S7.39
P/CF18.52

Share Price

Financials
201620172018
More ...
Income Statement
Revenue111,780.00111,696.00111,831.00
Operating Income48,432.0048,967.0047,248.00
Net Income37,925.0038,130.0038,628.00
Basic EPS14.9915.4215.96
Avg. Diluted Shares Outstanding2,5352,4782,425
Balance Sheet
Current Assets59,766.0060,080.0059,067.00
Non Current Assets37,773.0042,275.0051,702.00
Total Assets97,539.00102,355.00110,769.00
Current Liabilities47,436.0047,056.0054,164.00
Total Liabilities52,270.0052,540.0058,930.00
Total Equity45,269.0049,815.0051,839.00
Cash Flow
Operating Cash Flow48,314.0041,168.0044,616.00
Capital Expenditure-8,267.00-8,648.00-12,410.00
Free Cash Flow40,047.0032,520.0032,206.00

In millions, except "Basic EPS". Currency is DKK.

Company Profile

Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

43,161
Key Stats
More ...
Price/Earning TTM-
Price/Book15.84
Price/Sales TTM-
Rev Growth (3 year avg)1.19
EPS Growth (3 year avg)-
Operating Margin % TTM42.25
Net Margin % TTM34.54
ROE TTM76.00
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Date13/03/1807/08/18
Ex-Div23/03/1817/08/18
Paid03/04/1828/08/18
Amnt0.810.46
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.